Affymetrix (AFFX) Expands Genotyping Arrays Product Line

Zacks

Provider of life science tools and molecular diagnostic products, Affymetrix, Inc. (AFFX), is expected to highlight various new genotyping arrays at the 2015 Plant and Animal Genome Conference (PAGXXIII). The arrays are used primarily for applications in breeding and routine analysis.

Under the Axiom Expert Design Program, Affymetrix will provide the agriculture community access to two new arrays, namely, Axiom Porcine Genotyping Array and Axiom Equine Genotyping Array.

The arrays will be presented at the Affymetrix workshop, which will also include discussions by industry experts, on Jan 12 at PAG XXIII. The discussions will pertain to the latest genomic techniques for research and breeding in pigs, strawberry, and Medicago truncatula.

The two new arrays will be an addition to Affymetrix’s existing product portfolio that includes bovine, chicken, maize, salmon, and wheat. The company has launched a chain of new arrays with advanced content for genomic breeding in soybean, cotton, buffalo, rainbow trout, rose, strawberry and wheat.

Incidentally, Affymetrix holds a leading position in the genotyping business. The company has exclusively licensed technology from Peptide Groove LLP, which enables HLA typing of human samples from genotyping data generated from a variety of assays, including the company's Axiom genotyping assays.

Moreover, Affymetrix’s Axiom platform was recently selected by Toshiba Corp’s Healthcare Company as the platform for the latter’s newly launched genotyping service. Affymetrix has partnered with Toshiba to design and manufacture the Japonica Array, which is based on the Axiom platform. The Japonica Array contains unique genetic content, which has been specifically designed for the Japanese population.

We believe Affymetrix’s decision to expand its genotyping array portfolio will certainly help the company ramp up its existing customer base. Also, the expansion is expected to bode well for the company’s top-line growth, going forward.

Zacks Rank

Currently, Affymetrix sports a Zacks Rank #1 (Strong Buy). Some other stocks that warrant a look in the Medicine-Biomedicine/Genetic space are Alexion Pharmaceuticals (ALXN), AMAG Pharmaceuticals (AMAG) and NewLink Genetics Corp (NLNK). All the three stocks carry the same Zacks Rank as Affymetrix.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply